Boston Scientific, Mayo Clinic collaborate on medical device development

Boston Scientific and the Mayo Clinic announced on March 16 that they would continue to share intellectual property to develop medical devices that address unmet clinical needs in fields such as interventional cardiology, heart rhythm management, endoscopy, neuromodulation, urology and pelvic health.

Currently, there are several clinical programs underway, including a Mayo Clinic study evaluating a guide catheter for catheter-based aortic valve replacement. Another Mayo Clinic study is examining the use of Boston Scientific’s Precision Spectra Spinal Cord Stimulator System when patients with heart failure exercise.

Mayo Clinic Ventures is managing the collaboration between the companies. In 2015, the Mayo Clinic cared for 1.3 million patients.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."